23 24 post-castration. We used the MCRedAL prostate cancer cell line; an RFP expressing 66 version of the Myc-Cap cell line characterized by MYC overexpression 15 . Like human 67 prostate cancer, MCRedAL tumors are initially castration-sensitive (CS), but castration-68 resistance (CR) develops approximately 30 days after castration (Extended Data Fig. 1a ). 69 Pre-and post-ADT tumor cells were sorted to > 96% purity (Extended Data Fig. 1b ) and 70 analyzed ( Fig. 1a-b and Extended Data Fig. 1c ). A number of cytokine and chemokine 71 transcripts were significantly up-regulated post-ADT ( Fig. 1b right) , including Cxcl15, a 72 CXC chemokine with a conserved ELR motif (Extended Data Table 1) , which is the likely 73 murine homolog of human IL-8 (CXCL8) [16][17][18][19] . qRT-PCR and ELISA assays confirmed the 74 upregulation of Cxcl15 post-ADT at the protein level (Extended Data Fig. 1d ). In addition 75 to the chemokines above, GSEA revealed the upregulation of several pro-inflammatory 76 pathways post-ADT ( Fig. 1c ). In vitro experiments using the human androgen-responsive 77 LNCaP cell line corroborated a role for these pro-inflammatory signals, showing that in 78 the absence of androgen, TNFα upregulated IL-8 expression in a dose-dependent 79 manner ( Fig. 1d left) ; while AR signaling in the absence of inflammation did not affect IL-80 8 expression ( Fig. 1d right) . These data led to the hypothesis that AR signaling directly 81 suppresses IL-8 expression in prostate cancer cells. We performed in silico ChIP-Seq 82 analyses using human LNCaP cells (GSE83860) and found AR binding at the IL-8 83 promoter in the presence of the potent androgen dihydrotestosterone (DHT; Fig. 1e top) .
7
PMN-MDSCs, including up-regulation of IL-1b, Arg2 and IL-23a 14 (Fig. 3d ; Extended Data 134 Table 2 ). In particular, increased expression of IL-23a and Cxcr2 was verified by qRT-135 PCR ( Fig. 3e ) and flow cytometry (Extended Data Fig. 3d ). To test whether blocking the 136 IL-8/CXCR2 axis was sufficient to attenuate post-ADT PMN-MDSC infiltration, we treated 137 prostate-tumor bearing mice with anti-CXCR2 and found that blocking CXCR2 138 significantly diminished tumor infiltration with PMN-MDSCs in both human (PC3) and 139 murine (Myc-Cap) immunodeficient and immunocompetent models ( Fig. 3f and Extended 140 Data Fig. 3e-f ). To confirm this observation at the genetic level, we used CRISPR/Cas9 141 to generate human (PC3) and mouse (Myc-Cap) lines that were knocked out for human 142 IL-8 or the murine IL-8 homolog Cxcl15, respectively. We observed a clear decrease in 143 PMN-MDSC infiltration in both settings ( Fig. 3g and Extended Data Fig. 3e-f ). 144 We next asked whether the supernatants from castration-resistant MCRedAL (CR- Fig. 4j ). Similarly, Cxcl15 loss did not diminish the suppressive function 156 of PMN-MDSCs (Extended Data Fig. 4k ). Taken together these findings reinforce a 157 functional role for castration-mediated IL-8 secretion in PMN-MDSC migration. 158 Finally, we investigated the pre-clinical activity of blocking the IL-8/CXCR2 axis at the time 159 of androgen-deprivation in the Myc-Cap model.
Notably, in the absence of 160 immunotherapy the combination of ADT and CXCR2 blockade was not effective 161 (Extended Data Fig. 5a ). In contrast, combining CXCR2 blockade with ICB (anti-CTLA- Fig. 4d ), but rather correlated with an increase in polyfunctional effector CD8 T cells in 170 tumor-draining lymph nodes (TDLN) and spleens ( Fig. 4e&f ).
171
In summary, these studies showed that castration mediates increased IL-8 secretion by Correspondence and request for materials should be addressed to C.G.D.
231
(cgd2139@cumc.columbia.edu). Normalized expression of selected genes determined by NanoString nCounter gene For a more precise identification of cells expressing Cxcl15, RISH was coupled to 580 immunohistochemistry of PanCK (Poly; Dako) and CD45 (30-F11; BD Biosciences).
581
Immediately after RISH detection, samples were permeabilized with 0.2% TBS-Tween 20 582 for 10 minutes at RT, and then blocked with 2.5% of normal goat serum ( 
